Literature DB >> 1582376

Effects of intrauterine growth retardation and its subtypes on the development of the preterm infant.

M A Martikainen1.   

Abstract

The aim of this prospective study was to examine the neurological development of preterm children with asymmetric (A-SGA) or symmetric (S-SGA) intrauterine growth retardation (IUGR). Twenty-six A-SGA preterm children, 27 S-SGA preterm children and 131 appropriate for gestational age (AGA) preterm children were compared with 121 full-term AGA children. They were assessed by one author at the corrected age of 18 months +/- 2 weeks using the modified Denver Developmental Screening Test. Development was evaluated in terms of scores for fine motor and gross motor performance, for visuo-auditory perception, for speech and for social abilities. In the A-SGA group there were more children with low visuo-auditory perception scores and social abilities scores than in the control group. The S-SGA group differed from the other groups in all developmental sectors except visuo-auditory perception. Numbers of neurologically abnormal or suspect children in both SGA groups were twice the number in the control group. IUGR and sex were the only factors that correlated with slow neurological development. These results show that there will be a significant possibility of slow neurological development if a preterm baby has been subject to IUGR, especially symmetric IUGR.

Entities:  

Mesh:

Year:  1992        PMID: 1582376     DOI: 10.1016/0378-3782(92)90003-y

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  2 in total

1.  Minimal smoking cessation interventions in prenatal, family planning, and well-child public health clinics.

Authors:  C Manfredi; K S Crittenden; Y I Cho; J Engler; R Warnecke
Journal:  Am J Public Health       Date:  2000-03       Impact factor: 9.308

2.  Maternal cigarette smoking during pregnancy and infant ponderal index at birth in the Swedish Medical Birth Register, 1991-1992.

Authors:  A A Lindley; R H Gray; A A Herman; S Becker
Journal:  Am J Public Health       Date:  2000-03       Impact factor: 9.308

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.